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Rapid and accurate detection of norovirus is essential for the prevention and control of 
norovirus outbreaks. This study compared the effectiveness of a new immunochromato-
graphic assay kit (SD BIOLINE Norovirus; Standard Diagnostics, Korea) and real-time re-
verse transcription-PCR (RT-PCR) for detecting norovirus in fecal specimens. Compared 
with real-time RT-PCR, the new assay had sensitivity, specificity, positive predictive value, 
and negative predictive value of 76.5% (52/68), 99.7% (342/343), 98.1% (52/53), and 95.5% 
(342/358), respectively. The sensitivity of the assay was 81.8% (18/22) for GII.3 and 75.7% 
(28/37) for GII.4. None of the 38 enteric virus-positive specimens (3 for astrovirus, 5 for en-
teric adenovirus, and 30 for rotavirus) tested positive in the cross-reactivity test performed 
by using this assay. The new immunochromatographic assay may be a useful screening 
tool for the rapid detection of norovirus in sporadic and outbreak cases; however, negative 
results may require confirmatory assays of greater sensitivity.
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Noroviruses, which belong to the family Caliciviridae, are small 
non-enveloped RNA viruses that possess a linear, positive-sense, 
and single-stranded RNA genome. Noroviruses are genetically 
classified into 5 groups (GIV); GI, GII, and GIV cause human 
infections [1, 2]. Noroviruses are the most common cause of 
epidemic gastroenteritis, accounting for more than 23 million 
cases of gastroenteritis annually in the United States and about 
50% of all cases of outbreaks worldwide, and they are a signifi-
cant cause of sporadic cases of community-related gastroenteri-
tis [3-5]. Norovirus spreads easily because of several character-
istics such as a low infectious dose (as few as 10-100 particles), 
large quantities of the virus in feces and vomit, and environ-
mental stability [3, 4]. Thus, the rapid and accurate detection of 
norovirus is essential for the prevention and control of norovirus 
outbreaks.
  Methods used for the detection of norovirus in clinical speci-
mens include electron microscopy of fecal specimens, reverse 
transcription PCR (RT-PCR), real-time RT-PCR, enzyme immu-
noassays (EIAs), and immunochromatographic assays. An im-
munochromatographic assay is rapid, providing a result within 
30 min (usually between 15 and 30 min), but some assays have 
inadequate sensitivity for diagnosis of sporadic norovirus disease. 
Recently, a new immunochromatographic assay kit (SD BIOLINE 
Norovirus; Standard Diagnostics, Yongin, Korea) has been de-
veloped for the rapid detection of norovirus in fecal specimens. 
This study compared the effectiveness of this new immunochro-
matographic test kit and real-time RT-PCR assay for detecting 
norovirus in fecal specimens.
  A total of 411 fecal specimens from patients (inpatients and 
outpatients) presenting with symptoms of acute gastroenteritis 
were obtained between December 2010 and February 2011. The 
ages of the patients ranged from 5 weeks to 94 yr (average, 22.6 Park KS, et al.
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Table 1. Performance of the immunochromatographic test kit compared with real-time RT-PCR for the detection of norovirus
Real-time RT-PCR N of samples N of positive N of negative
Immunochromatography assay (95% CI)
Sensitivity Specificity PPV NPV
Positive   68 52   16
76.5 (65.1-85.0) 99.7 (98.4-99.9) 98.1 (90.1-99.7) 95.5 (92.9-97.2)
Negative* 343   1 342
*astrovirus-, adenovirus- or rotavirus-positive samples were included in negative samples.
Abbreviations: CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value.
yr). For the new immunochromatographic assay, stool suspen-
sions were prepared in 1 mL of a dilution buffer supplied in the 
kit; the assay was conducted according to the manufacturer’s 
instructions. For the molecular assay, each fecal specimen was 
diluted to yield a 10% suspension in phosphate-buffered saline 
and was clarified by centrifugation at 8,000×g for 15 min. The 
supernatants were collected and stored at -80°C until use. Viral 
RNA was extracted from 150 μL of each fecal supernatant by 
using a viral nucleic acid preparation kit (Greenmate Biotech, 
Seoul, Korea), in accordance with the manufacturer’s instruc-
tions. The extracted RNA was dissolved in 50 μL of nuclease-
free water and stored at -80°C until it was used for real-time and 
semi-nested RT-PCR.
  Real-time RT-PCR was conducted using an AccuPower
 ®No-
rovirus Real-Time RT-PCR Kit (Bioneer, Daejeon, Korea) in ac-
cordance with the manufacturer’s instructions; the 50-μL reac-
tion mixture contained 10 μL of RNA and each primer at a final 
concentration of 0.3 μM. Reverse transcription, amplification, 
and detection were performed using Exicycler
TM 96 (Bioneer) 
under the following conditions: initial hold at 45°C for 15 min and 
95°C for 5 min, followed by 45 cycles at 95°C for 5 sec, 55°C for 
5 sec, and 25°C for 1 min. Positive and negative control reactions 
were included in each run. A sample with threshold cycle (Ct) 
value <35 and a typical sigmoid curve was defined as positive. 
To determine the presence of PCR inhibitors, a mixture contain-
ing 5 μL of clarified fecal extract of the test specimen, 5 μL of 
clarified fecal extract of a known norovirus-positive specimen, 
and 130 μL of nuclease-free water was prepared, and the noro-
virus real-time RT-PCR was then carried out as described above. 
A negative real-time RT-PCR result was considered as evidence 
of the presence of PCR inhibitors. 
  In an effort to identify norovirus genotypes, we performed di-
rect sequencing of all samples that tested positive for norovirus 
by the real-time RT-PCR assay. For sequencing, semi-nested 
RT-PCR was conducted as described previously [6]. The prod-
ucts were purified using a QIAquick PCR Purification Kit (Qia-
gen, Valencia, CA, USA). The nucleotide sequences were deter-
mined using a BigDye Terminator Cycle Sequencing Kit (Applied 
Biosystems Foster City, CA, USA) with GI-R1M and GII-R1M 
primers in the 3730 XL DNA Analyzer (Applied Biosystems). A 
BLAST search of GenBank sequences was conducted to deter-
mine norovirus genotypes.
  Of the 411 fecal specimens, 68 tested positive by the real-time 
RT-PCR assay and 53 tested positive by the new assay. Among 
the PCR-negative specimens, none showed inhibition of PCR. 
Compared with real-time PCR, the new assay had sensitivity, 
specificity, positive predictive value, and negative predictive 
value of 76.5% (52/68), 99.7% (342/343), 98.1% (52/53), and 
95.5% (342/358), respectively (Table 1). The new assay detected 
the GII.1, GII.3, GII.4, GII.6, GII.8, and GII.11 genotypes, but not 
the GII.2 and GII.16 genotypes (Table 2). The sensitivity of the 
assay was 81.8% (18/22) for GII.3 and 75.7% (28/37) for GII.4.
  To evaluate the cross-reactivity of the new assay, we tested 343 
norovirus PCR-negative specimens by using real-time RT-PCR 
for other enteric viruses (astrovirus, enteric adenovirus, and ro-
tavirus). None of the other 38 enteric virus-positive specimens (3 
for astrovirus, 5 for enteric adenovirus, and 30 for rotavirus) tested 
positive by the new assay. For evaluation of the detection limits 
of the new assay, we prepared 5-fold serial dilutions of 6 fecal 
specimens (3 GII.3 and 3 GII.4 isolates), and each dilution was 
tested by using the new assay and real-time RT-PCR. Standard 
Table 2. Differences in the detectability of norovirus by the immu-
nochromatographic test kit according to the genotypes of genogroup 
II norovirus
Genotypes N of samples
Immunochromatography assay
Positive Negative
GII.1   1   1 0
GII.2   2   0 2
GII.3 22 18 4
GII.4 37 28 9
GII.6   1   1 0
GII.8   1   1 0
GII.11   2   2 0
GII.16   1   0 1
Non-typable   1   1 0Park KS, et al.
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curves were generated using reference norovirus RNA tran-
scripts (Bioneer). The number of RNA copies in a sample was 
determined on the basis of the CT value, and the corresponding 
numbers of genomic copies were extrapolated from the appro-
priate standard curve. The average lowest number of copies of 
GII.3 and GII.4 that could be detected by the new assay were 
1.7×10
7 and 9.5×10
7 RNA copies/g feces, respectively.
  Human noroviruses were first discovered by using electron 
microscopy. However, the usefulness of electron microscopy in 
clinical settings is limited because of the low sensitivity and time-
consuming nature of the technique, as well as the requirement 
for expensive equipment. Since the molecular cloning of the 
Norwalk virus genome in 1990 and the introduction of PCR as a 
diagnostic tool, molecular assays such as RT-PCR and real-time 
RT-PCR have been developed for the detection of norovirus [1]. 
Commercially available viral-antigen detection assays, which 
have been developed on the basis of the principle of EIA and 
immunochromatography, are easily available and can be used 
for rapid detection. EIA assays for detecting norovirus are highly 
specific, but vary in sensitivity from 32% to 90% [7, 8]. When a 
real-time RT-PCR assay was used as the gold standard test for 
comparison, the sensitivity of the immunochromatographic as-
says ranged from 57% to 82%, and the specificity ranged from 
98% to 100% [9-11]. However, when a conventional RT-PCR as-
say was used as the standard test for comparison, the sensitivity 
of the immunochromatographic assays ranged from 70% to 
79%, and the specificity ranged from 94% to 100% [8, 12, 13]. 
Although some antigen detection tests have inadequate sensi-
tivity for detecting sporadic cases, assays with high specificity 
may be useful to rapidly detect norovirus during outbreaks.
  The sensitivity of the new assay was comparable to that of the 
other immunochromatographic assays. Moreover, the results of 
the assay showed very high specificity for the detection of noro-
virus and no cross-reactivity for other enteric viruses. The sensi-
tivity of EIA and immunochromatographic assays is often geno-
type-dependent [4, 7]. The new assay displayed good sensitivity 
for a wide range of GII genotypes, except for GII.2 and GII.16; 
however, the number of samples containing some norovirus 
genotypes was too small to indicate statistical significance. Since 
the ability of the new assay to detect GI genotypes was not eval-
uated in this study, further studies are needed to evaluate the 
ability of this assay to detect GI genotypes.
  In conclusion, the new immunochromatographic assay may 
be a useful screening tool for the rapid detection of norovirus in 
sporadic and outbreak cases; however, a negative result may 
require confirmatory assays of greater sensitivity.
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